Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Sinopharm Group Co Ltd (1099)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
19.84 -0.36    -1.78%
04:08:04 - Closed. Currency in HKD ( Disclaimer )
  • Volume: 9,591,177
  • Bid/Ask: 19.84 / 19.86
  • Day's Range: 19.70 - 20.45
Type:  Equity
Market:  Hong Kong
ISIN:  CNE100000FN7 
Sinopharm Group Co 19.84 -0.36 -1.78%

1099 Balance Sheet

 
Featured here, the Balance Sheet for Sinopharm Group Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 336835.1 372666.2 372154.98 354869.69
Cash and Short Term Investments 67139.07 44263.81 34377.55 47196.88
Cash - - - -
Cash & Equivalents 63808.54 44263.41 34377.13 47196.44
Short Term Investments 3329.98 - - -
Total Receivables, Net 189796.9 250695.46 241477.38 227200.93
Accounts Receivables - Trade, Net 185790.36 243847.12 241477.38 220130.48
Total Inventory 60027.65 66293.5 66922.92 67325.75
Prepaid Expenses - - - -
Other Current Assets, Total 19871.49 11413.43 29377.13 13146.12
Total Assets 383394.84 419946.62 417691.5 401901.26
Property/Plant/Equipment, Total - Net 19897.66 16634.83 19655.37 16521.33
Property/Plant/Equipment, Total - Gross 36354.54 - - -
Accumulated Depreciation, Total -16456.88 - - -
Goodwill, Net 7185.73 7164.09 - 7171.47
Intangibles, Net 10196.15 4350.73 10138.7 4346.38
Long Term Investments 10550.69 10280.78 10089.04 10054.72
Note Receivable - Long Term 4006.54 6848.34 - 7070.45
Other Long Term Assets, Total 3157.65 3149.54 3542.67 5644.97
Other Assets, Total -110995.36 -167287.69 -143066.16 -143435.92
Total Current Liabilities 241490.64 278760.43 281306.63 265398.83
Accounts Payable 146632.45 159008.08 156639.23 149074
Payable/Accrued - - - -
Accrued Expenses 8831.77 1759.39 35158.61 1795.9
Notes Payable/Short Term Debt - 67928.87 - 53780.64
Current Port. of LT Debt/Capital Leases 56526.97 - 76300.4 -
Other Current liabilities, Total 29499.44 50064.1 13208.4 60748.3
Total Liabilities 263076.1 304013.11 304580.9 288794.15
Total Long Term Debt 17254.88 20841.14 18534.04 19031.04
Long Term Debt 13834.04 17447.19 15225.79 15773.33
Capital Lease Obligations 3420.84 3393.95 3308.25 3257.71
Deferred Income Tax 788.38 878.56 877.79 864.12
Minority Interest 45736.53 44168.58 43506.07 43268.66
Other Liabilities, Total -104690.2 -190941.75 -117591.18 -162266.99
Total Equity 120318.74 115933.52 113110.6 113107.11
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 3120.66 3120.66 3120.66 3120.66
Additional Paid-In Capital 24641.48 20433.48 - 20427.72
Retained Earnings (Accumulated Deficit) 51197.22 48194.59 - 46275.82
Treasury Stock - Common -3.84 -3.84 -3.84 -3.84
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 41363.23 44188.63 109993.78 43286.76
Total Liabilities & Shareholders' Equity 383394.84 419946.62 417691.5 401901.26
Total Common Shares Outstanding 1341.81 1341.81 1341.81 1341.81
Total Preferred Shares Outstanding - - - -
* In Millions of CNY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

1099 Comments

Write your thoughts about Sinopharm Group Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email